低血糖事件可能在糖尿病患者中在30天内引发急性缺血性中风:一个案例交叉研究
Supriya Makam1, Laura K Stein2, Mandip S Dhamoon2
1Icahn School of Medicine at Mount Sinai, New York, NY (S.M.).
Stroke
|November 22, 2024
概括
低血糖事件显著增加糖尿病患者急性缺血性中风 (AIS) 的风险,最高风险发生在事件发生后的第一天内. 避免低血糖是预防中风的关键.
科学领域:
- 神经学 神经学
- 内分泌学 在内分泌学.
- 心血管医学 心血管医学
背景情况:
- 低血糖是心血管事件的已知危险因素,包括急性缺血性中风 (AIS).
- 有限的研究存在于低血糖事件作为直接中风触发器.
- 这项研究调查了糖尿病患者低血糖和中风发生之间的关联.
研究的目的:
- 为了确定低血糖事件是否会成为糖尿病患者急性缺血性中风 (AIS) 的触发因素.
- 为了量化低血糖事件后AIS的风险.
主要方法:
- 利用了2016-2019年的医疗保险数据,用于住院,门诊,急诊和护理机构的接触.
- 采用一个案例交叉研究设计,将低血糖暴露后的AIS发生情况与对照期进行比较.
- 使用条件后勤回归来分析低血糖和AIS之间的关联.
主要成果:
- 在糖尿病患者中确定了237,667个AIS入院指数.
- 发现在低血糖遭遇后,AIS的几率显著增加.
- 风险在第一天 (OR 3.694) 最高,并且在30天 (OR 2.345) 后仍然显著.
结论:
- 低血糖事件与糖尿病患者的AIS风险大幅增加有关.
- 低血糖症后的AIS风险持续长达30天.
- 强调预防糖尿病患者低血糖至关重要,以减轻中风风险.
相关概念视频
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Diabetes: Symptoms, Diagnosis, and Complications
506
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
506
Oral Hypoglycemic Agents: Glinides
141
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively...
141
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
159
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
159
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K


